JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCHW
2126
CALL
Charles Schwab
SCHW
$186B
| $8.9M | ﹤0.01% |
173,200
+112,500
| +185% | +$5.29M |
|
2127
Orion
OEC
$377M
| $8.86M | ﹤0.01% |
345,886
+97,264
| +39% | +$2.3M |
|
2128
PUT
Kinder Morgan
KMI
$70.1B
| $8.85M | ﹤0.01% |
489,700
| – | – |
|
|
BMS
2129
DELISTED
Bemis
BMS
| $8.83M | ﹤0.01% |
184,875
+64,499
| +54% | +$2.98M |
|
2130
PUT
Exelixis
EXEL
$12.7B
| $8.82M | ﹤0.01% |
290,000
| – | – |
|
2131
CALL
Chipotle Mexican Grill
CMG
$40.5B
| $8.81M | ﹤0.01% |
1,525,000
+90,000
| +6% | +$537K |
|
2132
Hamilton Beach Brands
HBB
$445M
| $8.81M | ﹤0.01% |
+343,082
| New | +$11M |
|
|
GBT
2133
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $8.81M | ﹤0.01% |
223,879
-8,742
| -4% | -$327K |
|
2134
Cracker Barrel
CBRL
$1.25B
| $8.79M | ﹤0.01% |
55,314
+9,822
| +22% | +$1.54M |
|
2135
CALL
Accenture
ACN
$110B
| $8.79M | ﹤0.01% |
57,400
+16,100
| +39% | +$2.33M |
|
2136
INNOVATE Corp
VATE
$102M
| $8.76M | ﹤0.01% |
147,197
-10,253
| -7% | -$552K |
|
|
IPG
2137
DELISTED
Interpublic Group of Companies
IPG
| $8.76M | ﹤0.01% |
434,284
-195,755
| -31% | -$3.9M |
|
2138
Prosperity Bancshares
PB
$8.85B
| $8.75M | ﹤0.01% |
124,844
+71,385
| +134% | +$4.77M |
|
2139
CALL
Applied Materials
AMAT
$417B
| $8.74M | ﹤0.01% |
171,000
-114,300
| -40% | -$6.19M |
|
|
VIVO
2140
DELISTED
Meridian Bioscience Inc
VIVO
| $8.73M | ﹤0.01% |
623,331
+621,349
| +31,350% | +$9.1M |
|
2141
Harley-Davidson
HOG
$2.78B
| $8.72M | ﹤0.01% |
171,387
+104,447
| +156% | +$5.08M |
|
2142
Euronet Worldwide
EEFT
$2.64B
| $8.7M | ﹤0.01% |
103,220
-49,852
| -33% | -$4.61M |
|
2143
DNOW Inc
DNOW
$3.01B
| $8.7M | ﹤0.01% |
788,482
-473,315
| -38% | -$5.41M |
|
2144
Banco Macro
BMA
$5.14B
| $8.69M | ﹤0.01% |
75,002
-2,092
| -3% | -$245K |
|
2145
RPC Inc
RES
$1.4B
| $8.68M | ﹤0.01% |
340,045
+30,801
| +10% | +$742K |
|
2146
HUB Group
HUBG
$2.32B
| $8.68M | ﹤0.01% |
362,294
+15,682
| +5% | +$345K |
|
2147
iShares International Select Dividend ETF
IDV
$8.52B
| $8.64M | ﹤0.01% |
255,700
+12,210
| +5% | +$409K |
|
2148
TD Synnex
SNX
$20.3B
| $8.63M | ﹤0.01% |
127,022
-53,234
| -30% | -$3.52M |
|
2149
Amphastar Pharmaceuticals
AMPH
$869M
| $8.61M | ﹤0.01% |
447,410
+54,035
| +14% | +$1.01M |
|
2150
Ovintiv
OVV
$17.6B
| $8.6M | ﹤0.01% |
129,062
+29,749
| +30% | +$1.76M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.